Definitive Healthcare Corp. DH Proceeds from issuances of debt

Proceeds from issuances of debt at other companies

IQVIAIQV

——

SS&C TechnologiesSSNC

——

Revenue$55.9M-5.5%

Gross profit$46.6M-5.0%

Operating income-$201.3M-8.9%

Net income-$138.6M-29.3%

EPS (diluted)-$1.32-38.9%

Cash & equivalents$157.6M+48.6%

Total debt$169.8M-6.0%

Total assets$514.7M-36.3%

Operating cash flow$11.6M-55.6%

CapEx$3.2M-58.4%

Free cash flow$8.4M-54.5%

Market cap$87.68M-79.8%

Enterprise value$99.87M-81.2%

P/S0.4×-1.4×

Gross margin84.4%+1.0pp

Operating margin-101.1%-42.1pp

Net margin-71.5%-28.2pp

FCF margin12.1%-8.4pp

Current ratio1.8×0.0×

Reported directly by Definitive Healthcare Corp. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfDebt.

The official record: Definitive Healthcare Corp.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Definitive Healthcare Corp.'s proceeds from issuances of debt?: Definitive Healthcare Corp. (DH) reported proceeds from issuances of debt of $0 in Q1 2026.
How has Definitive Healthcare Corp.'s proceeds from issuances of debt changed year-over-year?: Definitive Healthcare Corp.'s proceeds from issuances of debt decreased by 100.0% year-over-year, from $175M to $0.